The Roles of Serum Leptin Concentration and Polymorphism in Leptin Receptor Gene at Codon 109 in Breast Cancer

Aims: We investigated the relationship between serum leptin concentrations and polymorphism of the leptin receptor gene and breast cancer. Methods: Serum leptin concentrations were measured by enzyme-linked immunosorbent assay in 47 women with invasive breast cancer compared with 41 age-matched controls without cancer. Genomic DNA was extracted from peripheral blood leukocytes. Genotyping of the leptin receptor gene at codon 109 (LEPR-109) was performed by polymerase chain reaction-restriction fragment length polymorphism. Results: Patients with breast cancer had a higher mean serum leptin concentration than women in the control group, but the difference was not statistically significant. Among those with breast cancer, the serum leptin concentration was higher in women with high-grade cancers (p = 0.020). The LEPR-109RR genotype was more frequent in premenopausal patients with tumors larger than 2 cm (p = 0.039) and in premenopausal women who were overweight (p = 0.029). Among patients with the LEPR-109RR genotype, higher mean serum leptin concentrations were present in those with triple-negative cancers (p = 0.048). Conclusions: Our study suggests an association between serum leptin concentration and tumor progression. LEPR-109 polymorphism in premenopausal women appears to be associated with obesity and tumor progression.

[1]  King-Jen Chang,et al.  Leptin interferes with adrenocorticotropin/3',5'-cyclic adenosine monophosphate (cAMP) signaling, possibly through a Janus kinase 2-phosphatidylinositol 3-kinase/Akt-phosphodiesterase 3-cAMP pathway, to down-regulate cholesterol side-chain cleavage cytochrome P450 enzyme in human adrenocortical NCI- , 2006, The Journal of clinical endocrinology and metabolism.

[2]  M. Hou,et al.  Serum adiponectin and leptin levels in Taiwanese breast cancer patients. , 2006, Cancer letters.

[3]  C. Ki,et al.  Relationships among serum leptin, leptin receptor gene polymorphisms, and breast cancer in Korea. , 2006, Cancer letters.

[4]  C. Perou,et al.  Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.

[5]  King-Jen Chang,et al.  Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1 , 2006, Breast Cancer Research and Treatment.

[6]  S. Schnitt,et al.  Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer , 2006, Modern Pathology.

[7]  T. Funahashi,et al.  High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels , 2006, International journal of cancer.

[8]  Lotfi Chouchane,et al.  Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma , 2006, BMC Cancer.

[9]  E. Taioli,et al.  Genetics of leptin and obesity: a HuGE review. , 2005, American journal of epidemiology.

[10]  Xuan Yang,et al.  Serum levels of leptin, insulin, and lipids in relation to breast cancer in China , 2005, Endocrine.

[11]  E. Surmacz,et al.  Leptin Interferes with the Effects of the Antiestrogen ICI 182,780 in MCF-7 Breast Cancer Cells , 2004, Clinical Cancer Research.

[12]  Jie Zhang,et al.  Potential involvement of leptin in carcinogenesis of hepatocellular carcinoma. , 2004, World journal of gastroenterology.

[13]  G. Werther,et al.  Antiapoptotic effects of leptin in human neuroblastoma cells. , 2004, Endocrinology.

[14]  Y. Shang,et al.  Molecular Mechanisms Involved in the Growth Stimulation of Breast Cancer Cells by Leptin , 2004, Cancer Research.

[15]  I. Borecki,et al.  Common variants in the 5' region of the leptin gene are associated with body mass index in men from the National Heart, Lung, and Blood Institute Family Heart Study. , 2004, American journal of human genetics.

[16]  P. Stattin,et al.  Plasma Leptin and Breast Cancer Risk: A Prospective Study in Northern Sweden , 2004, Breast Cancer Research and Treatment.

[17]  H. Nagawa,et al.  Enhanced Expression of Leptin and Leptin Receptor (OB-R) in Human Breast Cancer , 2004, Clinical Cancer Research.

[18]  C. Bouchard,et al.  Leptin and leptin receptor gene polymorphisms and changes in glucose homeostasis in response to regular exercise in nondiabetic individuals: the HERITAGE family study. , 2004, Diabetes.

[19]  L. Tessitore,et al.  Adipocyte expression and circulating levels of leptin increase in both gynaecological and breast cancer patients. , 2004, International journal of oncology.

[20]  D. Pinto,et al.  Overexpressing leptin genetic polymorphism (−2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease , 2004, The Prostate.

[21]  C. Giordano,et al.  Leptin Induces, via ERK1/ERK2 Signal, Functional Activation of Estrogen Receptor α in MCF-7 Cells* , 2004, Journal of Biological Chemistry.

[22]  K. Nakao,et al.  Association of Ob-R gene polymorphism and insulin resistance in Japanese men. , 2004, Metabolism: clinical and experimental.

[23]  M. Saad,et al.  Association of leptin receptor polymorphism with insulin resistance. , 2004, European journal of endocrinology.

[24]  J. E. Hewett,et al.  Leptin expression in breast nipple aspirate fluid (NAF) and serum is influenced by body mass index (BMI) but not by the presence of breast cancer. , 2004, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[25]  M. Forrest,et al.  Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[26]  C. Giordano,et al.  Leptin Enhances, via AP-1, Expression of Aromatase in the MCF-7 Cell Line* , 2003, Journal of Biological Chemistry.

[27]  D. Comings,et al.  A multigene test for the risk of sporadic breast carcinoma , 2003, Cancer.

[28]  Ki-Up Lee,et al.  Estrogen receptor alpha gene polymorphisms Pvu II and Xba I influence association between leptin receptor gene polymorphism (Gln223Arg) and bone mineral density in young men. , 2002, European journal of endocrinology.

[29]  D. Rose,et al.  Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review). , 2002, International journal of oncology.

[30]  N E Day,et al.  Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population‐based study , 2001, Genetic epidemiology.

[31]  N. Risch,et al.  The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[32]  R. Eastell,et al.  A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women , 2001, Human Genetics.

[33]  S. H. Cheng,et al.  Unique features of breast cancer in Taiwan , 2000, Breast Cancer Research and Treatment.

[34]  T. Price,et al.  Presence of leptin in breast cell lines and breast tumors. , 1999, Biochemical and biophysical research communications.

[35]  C K Osborne,et al.  Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  C. Mantzoros,et al.  Leptin in relation to carcinoma In situ of the breast: A study of pre‐menopausal cases and controls , 1999, International journal of cancer.

[37]  P. McKeigue,et al.  Leptin receptor gene variation and obesity: lack of association in a white British male population. , 1997, Human molecular genetics.

[38]  S. Klein,et al.  Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. , 1996, The Journal of clinical endocrinology and metabolism.

[39]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[40]  Y. Chagnon,et al.  Polymorphisms in the leptin and leptin receptor genes in relation to resting metabolic rate and respiratory quotient in the Québec Family Study , 2006, International Journal of Obesity.

[41]  P. Leung,et al.  Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells. , 2005, The Journal of clinical endocrinology and metabolism.

[42]  Xin Hu,et al.  Leptin--a growth factor in normal and malignant breast cells and for normal mammary gland development. , 2002, Journal of the National Cancer Institute.

[43]  C. Bouchard,et al.  Genetic factors as predictors of weight gain in young adult Dutch men and women , 2002, International Journal of Obesity.